China (Mainland)
Gefitinib CAS NO.184475-35-2
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Gefitinib
- Iressa
- 184475-35-2
Quick Details
- ProName: Gefitinib
- CasNo: 184475-35-2
- Molecular Formula: C22H24ClFN4O3
- Appearance: White Crystalline Powder
- Application: Pharmaceutical intermediates
- DeliveryTime: Within three or five working days
- PackAge: 1kg/bag,seald package or at customer r...
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.9%
- Storage: Sealed container
- Transportation: Sealed container at cool&dry place
- LimitNum: 1 Kilogram
- Heavy Metal: Not detected
- Valid Period: 2020-12-15
Superiority
1. Advanced Factory Building and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
| Gefitinib | CAS 184475-35-2 | Brand: HLT |
| MW:446.9 | MSDS: Avaiable | |
| MF:C22H24ClFN4O3 | Sample: Avaiable | |
| Category: API | Min order: 10grams | |
| Quality standard: 99.50% Purity | Place of Origin:China | |
| Usage: | Gefitinib is an EGFR (epidermal growth factor receptor)-tyrosine kinase inhibitor and has been shown to increase phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in HaCaT cells. Studies suggest that Gefitinib can enhance keratinocyte apoptosis via an EGFR-independent JNK-activation pathway. Research indicates that Gefitinib can induce apoptosis in several cell lines including, HaCaT cells, KG-1, P39, and primary CD34+ myeloblasts. Erlotinib (sc-202154) has similar properties to Gefitinib. | |
| Applications | Pharmaceutical raw materials | |
